课题基金 / 基金详情

METABOLIC EFFECTS OF NEWER ANTIPSYCHOTICS IN OLDER PATIENTS

METABOLIC EFFECTS OF NEWER ANTIPSYCHOTICS IN OLDER PATIENTS
新型抗精神病药对老年患者的代谢影响
批准号：
7724925
负责人：
DILIP V. JESTE
金额：
$14.52万
依托单位：
UNIVERSITY OF CALIFORNIA, SAN DIEGO
依托单位国家：
美国
项目类别：
财政年份：
2007
资助国家：
美国
项目状态：
已结题
起止时间：
2007-12-01 至 2008-11-30
来源：
https://reporter.nih.gov/project-details/7724925
关键词：
Antipsychotic AgentsComputer Retrieval of Information on Scientific Projects DatabaseFundingGrantInstitutionMetabolicQuality of lifeResearchResearch PersonnelResourcesRiskRisperidoneSourceUnited States National Institutes of Healtharipiprazolemiddle ageolanzapineolder patientquetiapine

项目摘要

项目成果

DILIP V. JESTE的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. Compare the risk of MCCE associated with four atypical agents: aripiprazole, olanzapine, quetiapine, and risperidone in middle aged and elderly patients. Examine the impact of anitpsychotic induced MCCE on everyday functioning and quality of life.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Multi-component Intervention for Diabetes in Adults with Serious Mental Illness (MIDAS)
Sustained Training in Aging and HIV Research (STAHR)
Sustained Training in Aging and HIV Research (STAHR)
Sustained Training in Aging and HIV Research (STAHR)